Skip to content

Vector Analysis of Body Composition in Hospitalized Cirrhotic Patients

Influence of Acute Decompensation on Body Composition Determined by Bioelectrical Impedance Vector Analysis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02017301
Enrollment
79
Registered
2013-12-20
Start date
2012-11-30
Completion date
2021-04-30
Last updated
2019-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection

Keywords

Liver Cirrhosis,Infection, Impedance, Body Composition

Brief summary

Patients with acute decompensation of cirrhosis, or acute on chronic liver failure often present with malnutrition, and due to the in-hospital stay, their nutritional intake can vary widely, with several periods of fasting, and sometimes insufficient nutritional support. Therefore patients are prone to develop malnutrition or, the already present malnutrition worsens its status. Our aim is to evaluate the daily changes in nutritional status in patients with acute decompensation of cirrhosis and evaluate the changes in plasma and serum biomarkers.

Interventions

OTHERNutritional assessment

Daily nutritional assessment with bioelectrical impedance vector analysis, phase angle and mid-arm muscle circumference

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-75 years old * Patients with confirmed cirrhosis. * Any etiology * Hospitalized with acute decompensation of cirrhosis * Signed informed consent

Exclusion criteria

* Pregnancy * Amputation * Incomplete data

Design outcomes

Primary

MeasureTime frameDescription
Changes in nutritional statusDaily measurement up to 30 daysNutritional status will be measured with bioelectrical impedance analysis (Vector and phase angle)

Secondary

MeasureTime frameDescription
Evaluation of inflammatory cytokinesSamples will be collected at the baseline evaluation.ELISA's test

Countries

Mexico

Contacts

Primary ContactAldo Torre Delgadillo, M.D. M.Sc
detoal@yahoo.com54870900
Backup ContactAstrid Ruiz-Margáin, M.Sc

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026